-
-
Login
Beta Bionics says its Mint patch pump will launch in 2027, taking aim at market leader Omnipod with a tubeless insulin pump that promises FreeStyle Libre compatibility, smartphone control and a fully adaptive insulin algorithm. But the bigger opportunity may not be winning over existing Omnipod users at all.
Reporting on the latest from Beta Bionics following FDA warning letter and insider share sales.
A look at the company's dramatic share price drop, iLet patient Numbers, CGM partnership with Abbott & the outlook for rollout in the UK/EU.
How to 'Go Bionic' with the iLet Bionic Pancreas.
